Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals

Lawrence C Layman, Paul G McDonough, David P. Cohen, Mary Maddox, Sandra P.T. Tho, Richard H. Reindollar

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Objective: To characterize the phenotype of idiopathic hypogonadotropic hypogonadism due to compound heterozygous GnRHR gene mutations (Arg262Gln/Tyr284Cys). Design: Retrospective review. Setting: Tertiary medical center. Patient(s): Family containing four siblings (three female and one male) with complete idiopathic hypogonadotropic hypogonadism. Intervention(s): Baseline and stimulated laboratory studies. One patient received GnRH treatment and one received human menopausal gonadotropins. Main Outcome Measure(s): Clinical phenotype vs. genotype is assessed by endocrine studies, karyotype, pedigree, and review of pathology slides of ovarian neoplasm. Result(s): With GnRH stimulation, two patients with idiopathic hypogonadotropic hypogonadism had maximum LH < 10 mIU/mL, and two others had peak LH > 10 mIU/mL. With repeated GnRH stimulation 24 hours later, gonadotropin levels in all patients were increased. Stimulation of thyroid-releasing hormone and tests for insulin-induced hypoglycemia were normal. One affected patient did not ovulate after GnRH treatment, but her sister ovulated with gonadotropin treatment. Another affected sibling had bilateral oophorectomy for seromucinous cystadenomas, and her hypogonadotropic state remained after castration. The man with idiopathic hypogonadotropic hypogonadism and his unaffected brother had a ring chromosome 21. Conclusion(s): All patients with complete idiopathic hypogonadotropic hypogonadism had the same GnRHR mutations, but clinical presentations and endocrinologic responses were heterogeneous. Gonadotropin levels remained low in patients with idiopathic hypogonadotropic hypogonadism after castration, and ring chromosome 21 was present, suggesting that sequences from this chromosome could affect the idiopathic hypogonadotropic hypogonadism phenotype.

Original languageEnglish (US)
Pages (from-to)1148-1155
Number of pages8
JournalFertility and Sterility
Volume75
Issue number6
DOIs
StatePublished - Jun 21 2001

Fingerprint

Hypogonadism
Gonadotropin-Releasing Hormone
Siblings
Gonadotropins
Castration
Phenotype
Cystadenoma
Menotropins
Mutation
Ovariectomy
Pedigree
Idiopathic Hypogonadotropic Hypogonadism
Karyotype
Thyroid Hormones
Hypoglycemia
Ovarian Neoplasms
Therapeutics
Chromosomes
Genotype
Outcome Assessment (Health Care)

Keywords

  • GnRH receptor
  • Idiopathic hypogonadotropic hypogonadism
  • Molecular genetics
  • Ring chromosome 21

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals. / Layman, Lawrence C; McDonough, Paul G; Cohen, David P.; Maddox, Mary; Tho, Sandra P.T.; Reindollar, Richard H.

In: Fertility and Sterility, Vol. 75, No. 6, 21.06.2001, p. 1148-1155.

Research output: Contribution to journalArticle

Layman, Lawrence C ; McDonough, Paul G ; Cohen, David P. ; Maddox, Mary ; Tho, Sandra P.T. ; Reindollar, Richard H. / Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals. In: Fertility and Sterility. 2001 ; Vol. 75, No. 6. pp. 1148-1155.
@article{029ce1d184564501b2adfbd62c1f3e44,
title = "Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals",
abstract = "Objective: To characterize the phenotype of idiopathic hypogonadotropic hypogonadism due to compound heterozygous GnRHR gene mutations (Arg262Gln/Tyr284Cys). Design: Retrospective review. Setting: Tertiary medical center. Patient(s): Family containing four siblings (three female and one male) with complete idiopathic hypogonadotropic hypogonadism. Intervention(s): Baseline and stimulated laboratory studies. One patient received GnRH treatment and one received human menopausal gonadotropins. Main Outcome Measure(s): Clinical phenotype vs. genotype is assessed by endocrine studies, karyotype, pedigree, and review of pathology slides of ovarian neoplasm. Result(s): With GnRH stimulation, two patients with idiopathic hypogonadotropic hypogonadism had maximum LH < 10 mIU/mL, and two others had peak LH > 10 mIU/mL. With repeated GnRH stimulation 24 hours later, gonadotropin levels in all patients were increased. Stimulation of thyroid-releasing hormone and tests for insulin-induced hypoglycemia were normal. One affected patient did not ovulate after GnRH treatment, but her sister ovulated with gonadotropin treatment. Another affected sibling had bilateral oophorectomy for seromucinous cystadenomas, and her hypogonadotropic state remained after castration. The man with idiopathic hypogonadotropic hypogonadism and his unaffected brother had a ring chromosome 21. Conclusion(s): All patients with complete idiopathic hypogonadotropic hypogonadism had the same GnRHR mutations, but clinical presentations and endocrinologic responses were heterogeneous. Gonadotropin levels remained low in patients with idiopathic hypogonadotropic hypogonadism after castration, and ring chromosome 21 was present, suggesting that sequences from this chromosome could affect the idiopathic hypogonadotropic hypogonadism phenotype.",
keywords = "GnRH receptor, Idiopathic hypogonadotropic hypogonadism, Molecular genetics, Ring chromosome 21",
author = "Layman, {Lawrence C} and McDonough, {Paul G} and Cohen, {David P.} and Mary Maddox and Tho, {Sandra P.T.} and Reindollar, {Richard H.}",
year = "2001",
month = "6",
day = "21",
doi = "10.1016/S0015-0282(01)01782-4",
language = "English (US)",
volume = "75",
pages = "1148--1155",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Familial gonadotropin-releasing hormone resistance and hypogonadotropic hypogonadism in a family with multiple affected individuals

AU - Layman, Lawrence C

AU - McDonough, Paul G

AU - Cohen, David P.

AU - Maddox, Mary

AU - Tho, Sandra P.T.

AU - Reindollar, Richard H.

PY - 2001/6/21

Y1 - 2001/6/21

N2 - Objective: To characterize the phenotype of idiopathic hypogonadotropic hypogonadism due to compound heterozygous GnRHR gene mutations (Arg262Gln/Tyr284Cys). Design: Retrospective review. Setting: Tertiary medical center. Patient(s): Family containing four siblings (three female and one male) with complete idiopathic hypogonadotropic hypogonadism. Intervention(s): Baseline and stimulated laboratory studies. One patient received GnRH treatment and one received human menopausal gonadotropins. Main Outcome Measure(s): Clinical phenotype vs. genotype is assessed by endocrine studies, karyotype, pedigree, and review of pathology slides of ovarian neoplasm. Result(s): With GnRH stimulation, two patients with idiopathic hypogonadotropic hypogonadism had maximum LH < 10 mIU/mL, and two others had peak LH > 10 mIU/mL. With repeated GnRH stimulation 24 hours later, gonadotropin levels in all patients were increased. Stimulation of thyroid-releasing hormone and tests for insulin-induced hypoglycemia were normal. One affected patient did not ovulate after GnRH treatment, but her sister ovulated with gonadotropin treatment. Another affected sibling had bilateral oophorectomy for seromucinous cystadenomas, and her hypogonadotropic state remained after castration. The man with idiopathic hypogonadotropic hypogonadism and his unaffected brother had a ring chromosome 21. Conclusion(s): All patients with complete idiopathic hypogonadotropic hypogonadism had the same GnRHR mutations, but clinical presentations and endocrinologic responses were heterogeneous. Gonadotropin levels remained low in patients with idiopathic hypogonadotropic hypogonadism after castration, and ring chromosome 21 was present, suggesting that sequences from this chromosome could affect the idiopathic hypogonadotropic hypogonadism phenotype.

AB - Objective: To characterize the phenotype of idiopathic hypogonadotropic hypogonadism due to compound heterozygous GnRHR gene mutations (Arg262Gln/Tyr284Cys). Design: Retrospective review. Setting: Tertiary medical center. Patient(s): Family containing four siblings (three female and one male) with complete idiopathic hypogonadotropic hypogonadism. Intervention(s): Baseline and stimulated laboratory studies. One patient received GnRH treatment and one received human menopausal gonadotropins. Main Outcome Measure(s): Clinical phenotype vs. genotype is assessed by endocrine studies, karyotype, pedigree, and review of pathology slides of ovarian neoplasm. Result(s): With GnRH stimulation, two patients with idiopathic hypogonadotropic hypogonadism had maximum LH < 10 mIU/mL, and two others had peak LH > 10 mIU/mL. With repeated GnRH stimulation 24 hours later, gonadotropin levels in all patients were increased. Stimulation of thyroid-releasing hormone and tests for insulin-induced hypoglycemia were normal. One affected patient did not ovulate after GnRH treatment, but her sister ovulated with gonadotropin treatment. Another affected sibling had bilateral oophorectomy for seromucinous cystadenomas, and her hypogonadotropic state remained after castration. The man with idiopathic hypogonadotropic hypogonadism and his unaffected brother had a ring chromosome 21. Conclusion(s): All patients with complete idiopathic hypogonadotropic hypogonadism had the same GnRHR mutations, but clinical presentations and endocrinologic responses were heterogeneous. Gonadotropin levels remained low in patients with idiopathic hypogonadotropic hypogonadism after castration, and ring chromosome 21 was present, suggesting that sequences from this chromosome could affect the idiopathic hypogonadotropic hypogonadism phenotype.

KW - GnRH receptor

KW - Idiopathic hypogonadotropic hypogonadism

KW - Molecular genetics

KW - Ring chromosome 21

UR - http://www.scopus.com/inward/record.url?scp=0035003309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035003309&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(01)01782-4

DO - 10.1016/S0015-0282(01)01782-4

M3 - Article

VL - 75

SP - 1148

EP - 1155

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -